Novak & Powell Financial Services’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.52M Sell
10,326
-35
-0.3% -$8.15K 1.36% 18
2025
Q4
$2.14M Sell
10,361
-127
-1% -$25.1K 1.12% 21
2025
Q3
$1.94M Buy
10,488
+2,754
+36% +$472K 1.02% 20
2025
Q2
$1.18M Sell
7,734
-313
-4% -$48.1K 0.82% 24
2025
Q1
$1.33M Buy
8,047
+98
+1% +$15.3K 0.83% 34
2024
Q4
$1.15M Sell
7,949
-2,037
-20% -$316K 0.68% 36
2024
Q3
$1.62M Sell
9,986
-135
-1% -$21.5K 0.94% 30
2024
Q2
$1.48M Buy
10,121
+130
+1% +$19.3K 0.92% 31
2024
Q1
$1.58M Sell
9,991
-131
-1% -$20.9K 1.18% 20
2023
Q4
$1.59M Buy
+10,122
New +$1.55M 1.06% 22

Other funds holding JNJ

Novak & Powell Financial Services's JNJ Position: Q1 2026 in Review

Novak & Powell Financial Services reduced its Johnson & Johnson (JNJ) stake by 0.34% in Q1 2026, selling an estimated $8.15K and leaving 10,326 shares worth $2.52M. The position accounts for 1.36% of the portfolio, ranked #18.

Novak & Powell Financial Services first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Novak & Powell Financial Services held 10,326 shares of Johnson & Johnson worth $2.52M as of Q1 2026.
  • Novak & Powell Financial Services sold 35 Johnson & Johnson shares in Q1 2026, an estimated $8.15K.
  • Johnson & Johnson made up 1.36% of Novak & Powell Financial Services's portfolio in Q1 2026, its #18 holding.
  • Novak & Powell Financial Services first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Novak & Powell Financial Services's 13F filing for Q1 2026, filed 14 May 2026.